{"DataElement":{"publicId":"3444616","version":"1","preferredName":"Uterine Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage","preferredDefinition":"Extent of the primary uterine carcinoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"3444515v1.0:3444543v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3444515","version":"1","preferredName":"Corpus Uteri Neoplasm Pathologic T Stage","preferredDefinition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Caused by or altered by or manifesting disease or pathology._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"3444507v1.0:2207099v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3444507","version":"1","preferredName":"Corpus Uteri Neoplasm","preferredDefinition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12316:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Corpus Uteri","conceptCode":"C12316","definition":"The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CE75-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CEEF-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3444543","version":"1","preferredName":"Corpus Uteri Carcinoma American Joint Committee on Cancer (AJCC) Edition 7 T Stage","preferredDefinition":"A finding about one or more characteristics of uterine corpus carcinoma, following the rules of the TNM AJCC v7 classification system.  Carcinosarcomas should be staged as carcinoma. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3444543v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":"Uterine Corpus Carcinoma pT0 TNM Finding v7","ValueMeaning":{"publicId":"3444545","version":"1","preferredName":"Uterine Corpus Carcinoma pT0 TNM Finding v7","longName":"3444545","preferredDefinition":"Uterine corpus carcinoma in which there is no evidence of a primary tumor. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pT0 TNM Finding v7","conceptCode":"C89558","definition":"Uterine corpus carcinoma in which there is no evidence of a primary tumor. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CFB0-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-CFC9-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"T1","valueDescription":"Uterine Corpus Carcinoma pT1 TNM Finding v7","ValueMeaning":{"publicId":"3444547","version":"1","preferredName":"Uterine Corpus Carcinoma pT1 TNM Finding v7","longName":"3444547","preferredDefinition":"Uterine corpus carcinoma with tumor confined to uterine corpus. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pT1 TNM Finding v7","conceptCode":"C89560","definition":"Uterine corpus carcinoma with tumor confined to uterine corpus. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CFD6-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-CFEF-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Uterine Corpus Carcinoma pT1a TNM Finding v7","ValueMeaning":{"publicId":"3444549","version":"1","preferredName":"Uterine Corpus Carcinoma pT1a TNM Finding v7","longName":"3444549","preferredDefinition":"Uterine corpus carcinoma with tumor limited to endometrium or invading less than one-half of the myometrium. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pT1a TNM Finding v7","conceptCode":"C89561","definition":"Uterine corpus carcinoma with tumor limited to endometrium or invading less than one-half of the myometrium. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CFFC-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D015-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Uterine Corpus Carcinoma pT1b TNM Finding v7","ValueMeaning":{"publicId":"3444551","version":"1","preferredName":"Uterine Corpus Carcinoma pT1b TNM Finding v7","longName":"3444551","preferredDefinition":"Uterine corpus carcinoma with tumor invading one-half or more of the myometrium. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pT1b TNM Finding v7","conceptCode":"C89562","definition":"Uterine corpus carcinoma with tumor invading one-half or more of the myometrium. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D022-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D03B-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"T2","valueDescription":"Uterine Corpus Carcinoma pT2 TNM Finding v7","ValueMeaning":{"publicId":"3444553","version":"1","preferredName":"Uterine Corpus Carcinoma pT2 TNM Finding v7","longName":"3444553","preferredDefinition":"Uterine corpus carcinoma that invades stromal connective tissue of the cervix but does not extend beyond uterus.  Endocervical glandular involvement only should be considered as Stage I and not as Stage II. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pT2 TNM Finding v7","conceptCode":"C89563","definition":"Uterine corpus carcinoma that invades stromal connective tissue of the cervix but does not extend beyond uterus.  Endocervical glandular involvement only should be considered as Stage I and not as Stage II. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D048-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D061-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"T3a","valueDescription":"Uterine Corpus Carcinoma pT3a TNM Finding v7","ValueMeaning":{"publicId":"3444557","version":"1","preferredName":"Uterine Corpus Carcinoma pT3a TNM Finding v7","longName":"3444557","preferredDefinition":"Uterine corpus carcinoma that involves serosa and/or adnexa (direct extension or metastasis). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pT3a TNM Finding v7","conceptCode":"C89565","definition":"Uterine corpus carcinoma that involves serosa and/or adnexa (direct extension or metastasis). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D094-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D0AD-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"T3b","valueDescription":"Uterine Corpus Carcinoma pT3b TNM Finding v7","ValueMeaning":{"publicId":"3444559","version":"1","preferredName":"Uterine Corpus Carcinoma pT3b TNM Finding v7","longName":"3444559","preferredDefinition":"Uterine corpus carcinoma that involves vagina or parametrial tissue.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pT3b TNM Finding v7","conceptCode":"C89566","definition":"Uterine corpus carcinoma that involves vagina or parametrial tissue.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D0BA-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D0D3-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"T4","valueDescription":"Uterine Corpus Carcinoma pT4 TNM Finding v7","ValueMeaning":{"publicId":"3444561","version":"1","preferredName":"Uterine Corpus Carcinoma pT4 TNM Finding v7","longName":"3444561","preferredDefinition":"Uterine corpus carcinoma that invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pT4 TNM Finding v7","conceptCode":"C89567","definition":"Uterine corpus carcinoma that invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D0E0-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D0F9-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Uterine Corpus Carcinoma pTis TNM Finding v7","ValueMeaning":{"publicId":"3444563","version":"1","preferredName":"Uterine Corpus Carcinoma pTis TNM Finding v7","longName":"3444563","preferredDefinition":"Uterine corpus carcinoma with a finding of carcinoma in situ (preinvasive carcinoma).  FIGO no longer includes Stage 0 (Tis). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pTis TNM Finding v7","conceptCode":"C89559","definition":"Uterine corpus carcinoma with a finding of carcinoma in situ (preinvasive carcinoma).  FIGO no longer includes Stage 0 (Tis). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D106-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D11F-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"},{"value":"TX","valueDescription":"Uterine Corpus Carcinoma pTX TNM Finding v7","ValueMeaning":{"publicId":"3444565","version":"1","preferredName":"Uterine Corpus Carcinoma pTX TNM Finding v7","longName":"3444565","preferredDefinition":"Uterine corpus carcinoma in which primary tumor cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma pTX TNM Finding v7","conceptCode":"C89557","definition":"Uterine corpus carcinoma in which primary tumor cannot be assessed. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-D12C-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE75A97-D145-0ED3-E040-BB89AD4366E2","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3444542","version":"1","preferredName":"Uterine Corpus Carcinoma TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A finding about one or more characteristics of uterine corpus carcinoma, following the rules of the TNM AJCC v7 classification system.  Carcinosarcomas should be staged as carcinoma. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89554:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Carcinoma TNM Finding v7","conceptCode":"C89554","definition":"A finding about one or more characteristics of uterine corpus carcinoma, following the rules of the TNM AJCC v7 classification system.  Carcinosarcomas should be staged as carcinoma. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CF85-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"ONEDATA","dateModified":"2012-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE75A97-CF96-0ED3-E040-BB89AD4366E2","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3444894","version":"1","longName":"Corpus Uteri Carcinoma","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777530","version":"1","longName":"Uterine","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Pathologic T Stage","type":"Preferred Question Text","description":"Pathologic T Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BEE854C9-9DDF-50CA-E040-BB89AD4341D5","latestVersionIndicator":"Yes","beginDate":"2012-04-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-30","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}